A pharmaceutical company from Moderna, the company that developed one of the covid vaccines, thinks that vaccines against cancer, cardiovascular disease and autoimmune diseases will be ready by 2030.
According to news from the The protectorstudies of these vaccines show “huge promise” as progress has been made in 12 to 18 months, after the work done to achieve the Covid-19 vaccine.
The company that made one of the Covid-19 vaccines, Moderna, believes it can offer vaccines and treatments for various types of illnesses in less than five years.
“We will have this vaccine and it will be very effective and save many hundreds of thousands of people, if not millions of lives. I think we will be able to offer personalized vaccines against cancer and different types of tumours,” said Dr Paul Burton , director of the pharmaceutical industry, quoted by The Guardian.
Paul Burton also says some respiratory infections can be treated with a single vaccine and that mRNA therapies, which teach cells to produce the protein that triggers the body’s immune response against the disease, will become available for rare diseases for which there are currently no drugs.
However, according to the The protectorscientists argue that accelerated progress may be in vain if high levels of investment are not maintained.
“The mRA can be applied to different types of disease. We have studies in all these areas and they all showed promise,” said Paul Burton.
Moderna had already presented results from a test conducted with an mRNA vaccine for RSV that was 83.7% effective in preventing at least two symptoms, such as cough and fever, in adults aged 60 and older.
The Pfizer company has also begun studies for an mRNA-based flu vaccine and plans to move into other infectious diseases, including shingles, in collaboration with BioNTech.
Source: DN
